Clinical Trial Update: Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a MEK inhibitor combined with a PI3K/mTOR inhibitor in subjects with locally advanced or metastatic solid tumors; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• MEK inhibitor (unspecified) (MEK inhibitor)
• PI3K/mTOR inhibitor (unspecified)

Snippet

Sponsor: EMD Serono | Conditions: Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2017-03-07